Who will be attending
- Global CDMOs and CMOs leading innovation in small molecule, biologics, and cell & gene therapy manufacturing.
- Big Pharma outsourcing executives seeking capacity and strategic partners.
- Regulatory experts from the FDA and other government offices offering direct insights.
- Private equity and investment firms exploring partnerships and acquisitions.
- Emerging innovators in automation, data, AI, and sustainable manufacturing.
- Bold new voices unafraid to tackle tough questions about the industry’s future.











